Jaguar Health (JAGX) Shares Gap Down to $0.14

Share on StockTwits

Jaguar Health, Inc. (NASDAQ:JAGX)’s share price gapped down prior to trading on Wednesday . The stock had previously closed at $0.13, but opened at $0.14. Jaguar Health shares last traded at $0.15, with a volume of 6628 shares traded.

Separately, ValuEngine upgraded Jaguar Health from a “strong sell” rating to a “sell” rating in a report on Friday, February 2nd.

The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.91 and a current ratio of 1.16.

About Jaguar Health

Jaguar Health, Inc, a commercial stage natural-products pharmaceuticals company, focuses on developing gastrointestinal products for human prescription use and animals worldwide. The company, through its wholly-owned subsidiary, Napo Pharmaceuticals, Inc, focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas.

Receive News & Ratings for Jaguar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Jaguar Health and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Fox Run Management L.L.C. Purchases 8,011 Shares of Patterson Companies, Inc.
Fox Run Management L.L.C. Purchases 8,011 Shares of Patterson Companies, Inc.
Contrasting General Motors  & Spartan Motors
Contrasting General Motors & Spartan Motors
Fox Run Management L.L.C. Takes Position in Prologis Inc
Fox Run Management L.L.C. Takes Position in Prologis Inc
23,332 Shares in First Data Corp  Purchased by Fox Run Management L.L.C.
23,332 Shares in First Data Corp Purchased by Fox Run Management L.L.C.
880 Shares in Ulta Beauty Inc  Acquired by Capital One National Association
880 Shares in Ulta Beauty Inc Acquired by Capital One National Association
Financial Comparison: Check Point Software Technologies  and Microsoft
Financial Comparison: Check Point Software Technologies and Microsoft


© 2006-2018 Ticker Report. Google+.